1.285USD-0.77%Mkt Cap: 110.81M USDP/E: —Last update: 2026-06-01
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to …
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap110.81M USD
Enterprise Value113.22M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-26.61M USD
Revenue/Share—
Last Price1.285 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees42
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.77
PEG—
EV/EBITDA-4.14
EV/Revenue—
P/S—
P/B5.87
EPS (TTM)-0.40
EPS (Forward)-0.35
52W Range
0.923036% of range1.920
52W High1.920 USD
52W Low0.9230 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-169.16%
ROA-67.55%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-24.32M USD
CapEx (TTM)1.17M USD
FCF Margin—
FCF Yield-14.78%
Net Debt-1.47M USD
Net Debt/EBITDA0.05
Balance Sheet
Debt/Equity1.20
Current Ratio3.18
Quick Ratio3.02
Book Value/Sh0.2250 USD
Cash/Share0.2290 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 6, 2020
Splits
Last Split1:3
Split DateAug 19, 2022
Analyst Consensus
Rating—
Target (Mean)4.833 USD
Target Range3.500 USD – 7.000 USD
# Analysts3
Ownership
Shares Out.86.24M
Float38.86M
Insiders57.94%
Institutions6.50%
Short Interest
Short Ratio1.2d
Short % Float0.90%
Short % Out.0.46%
Shares Short392.63K
Short (prev mo.)529.86K
Technical
SMA 501.196 (+7.4%)
SMA 2001.314 (-2.2%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)239.35K
Avg Vol (10d)229.07K
Technical Indicators
RSI (14)58.2
MACD0.0060
MACD Signal-0.0047
MACD Hist.+0.0107
BB Upper1.348 USD
BB Middle1.219 USD
BB Lower1.090 USD
BB Width21.15%
ATR (14)0.0672 USD
Vol Ratio (20d)0.39x